Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents
- 1 January 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (1) , 241-244
- https://doi.org/10.1128/aac.39.1.241
Abstract
Vibrio cholerae O139 (173 strains) and O1 (221 strains) were tested for their in vitro susceptibilities to 39 antimicrobial agents. Both O139 and O1 strains were highly susceptible to azithromycin, cephems, minocycline, penems, and newer fluoroquinolones. O139 strains (94.8%), O1 Indian El Tor strains (97%), and Bangladeshi El Tor strains (50%) were highly resistant to streptomycin, sulfamethoxazole, and trimethoprim and moderately resistant to chloramphenicol and furazolidone, in sharp contrast to O1 Peruvian El Tor and O1 classical strains. Some Bangladeshi El Tor strains (43.3%) showed tetracycline resistance as well.Keywords
This publication has 21 references indexed in Scilit:
- Vibrio cholerae 0139 in Karachi, PakistanThe Lancet, 1993
- Non-01 Vibrio choleraeThe Lancet, 1993
- Vibrio cholerae 0139 Bengal in BangkokThe Lancet, 1993
- Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfioxacin, tosufloxacin, CI-960 and CI-990Journal of Antimicrobial Chemotherapy, 1993
- Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern IndiaThe Lancet, 1993
- Large outbreak of clinical cholera due to Vibrio cholerae non-01 in BangladeshThe Lancet, 1993
- Localized, Aggregative, and Diffuse Adherence to HeLa Cells, Plastic, and Human Small Intestines by Escherichi coli Isolated from Patients with DiarrheaThe Journal of Infectious Diseases, 1992
- Comparative Antibacterial Activity of the Penem ALP 201Chemotherapy, 1991
- Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (Second of Two Parts)Mayo Clinic Proceedings, 1985
- Controlled Comparison of Tetracycline and Furazolidone in CholeraBMJ, 1968